EBS Market Analysis
Wall Street coverage
third-party contextWall Street coverage
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
News & Sentiment
50 articles · sorted by dateVia 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeValuation
- Forward P/E
- 22.99
- PEG ratio
- 0.38
- P/B
- 1.00
- P/S (TTM)
- 0.42
- EV/EBITDA
- 5.24
Profitability & growth
- ROE (TTM)
- -40.3%
- Operating margin
- 28.3%
- Revenue growth YoY
- 66.3%
- Dividend yield
- —
- Beta
- 2.29
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Emergent Biosolutions Inc
Company profileEmergent BioSolutions Inc., a life sciences company, focuses on providing preparedness and response products and solutions for civilian and military populations that address accidental, deliberate, and naturally occurring public health threats (PHT). The company is headquartered in Gaithersburg, Maryland.
Classification
- Sector
- Healthcare
- Exchange
- NYSE
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 300 PROFESSIONAL DRIVE, GAITHERSBURG, MD
- Fiscal year end
- December
- Latest quarter
- Jun 30, 2026
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
